| NCT ID | NCT06759428 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erasmus Medical Center |
| Condition | Chronic Subdural Hematoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2021-10-01 |
| Primary Completion | 2027-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2021-10-01 with a primary completion date of 2027-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to better understand how chronic subdural hematoma (CSDH) progresses and how patients are treated and cared for. The study focuses on three main questions: 1. What are the characteristics of patients with CSDH when they are diagnosed? 2. What treatments do patients with CSDH receive? 3. What are the outcomes for patients with CSDH, including their functional ability, cognitive health, and neurological status? Participants will receive their usual standard treatment. As part of the study, they will complete a brief telephone interview three months after their treatment.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with CSDH * 18 years or older Exclusion Criteria: * Patients who do not consent to participate in the registry
Contact & Investigator
Ruben Dammers
PRINCIPAL INVESTIGATOR
Erasmus Medical Center
Frequently Asked Questions
Who can join the NCT06759428 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Subdural Hematoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06759428 currently recruiting?
Yes, NCT06759428 is actively recruiting participants. Contact the research team at r.fakhry@erasmusmc.nl for enrollment information.
Where is the NCT06759428 trial being conducted?
This trial is being conducted at Amsterdam, Netherlands, Rotterdam, Netherlands.
Who is sponsoring the NCT06759428 clinical trial?
NCT06759428 is sponsored by Erasmus Medical Center. The principal investigator is Ruben Dammers at Erasmus Medical Center. The trial plans to enroll 1,500 participants.